Jiuda Zhao

LBA53 Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III study

Jianming Xu, Hong Jiang, Yueyin Pan et al. · Annals of Oncology · 2021 · 128 citations

Medicine, Oncology, Pharmacotherapy +13

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Meiqi Shi, Hai‐Yan Tu, Cheng Huang et al. · Annals of Oncology · 2020 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

Hongnan Mo, Xiaoyan Yan, Fang Zhao et al. · JAMA Network Open · 2022 · 51 citations · Full text

Medicine, Oncology, Pharmacology +15

S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer

Feng Du, Zhaoxu Zheng, Susheng Shi et al. · Medicine · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +15

Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection

Feng Du, Zhiwei Sun, Jun Jia et al. · Journal of Cancer · 2020 · 44 citations · Full text

Medicine, Oncology, Surgery +17